Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Cleveland

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Gene|June 1, 2002
A novel Eyes Absent 2 protein is expressed in the human eyeBrian E Fee, Christina A Doyle, John L Cleveland
The Journal of Biological Chemistry|November 9, 2001
Misexpression of the eyes absent family triggers the apoptotic programS Wesley Clark, Brian E Fee, John L Cleveland
Medical Sciences (Basel, Switzerland)|March 9, 2018
Role of Polyamines in Immune Cell FunctionsRebecca S Hesterberg, John L Cleveland, Pearlie K Epling-Burnette
The Journal of Organic Chemistry|February 2, 2016
Synthesis and Cytoxicity of Sempervirine and AnaloguesXiaohong Pan, Chunying Yang, John L Cleveland, et al.
Plos One|December 27, 2014
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolinMohammad Fallahi, Antonio L Amelio, John L Cleveland, et al.
Biologics : Targets & Therapy|August 27, 2009
Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistanceJennifer S Carew, Steffan T Nawrocki, Francis J Giles, et al.
Cancer Research|April 4, 2002
Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient miceChristine M Eischen, Jerold E Rehg, Stanley J Korsmeyer, et al.
Annals of Translational Medicine|January 17, 2017
CK1δ: an exploitable vulnerability in breast cancerLaura H Rosenberg, John L Cleveland, William R Roush, et al.
The EMBO Journal|March 12, 2003
Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesisJodi R Alt, Timothy C Greiner, John L Cleveland, et al.
The Journal of Clinical Investigation|December 22, 2007
Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesisKirsteen H Maclean, Frank C Dorsey, John L Cleveland, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Gene|June 1, 2002
A novel Eyes Absent 2 protein is expressed in the human eyeBrian E Fee, Christina A Doyle, John L Cleveland
The Journal of Biological Chemistry|November 9, 2001
Misexpression of the eyes absent family triggers the apoptotic programS Wesley Clark, Brian E Fee, John L Cleveland
Medical Sciences (Basel, Switzerland)|March 9, 2018
Role of Polyamines in Immune Cell FunctionsRebecca S Hesterberg, John L Cleveland, Pearlie K Epling-Burnette
The Journal of Organic Chemistry|February 2, 2016
Synthesis and Cytoxicity of Sempervirine and AnaloguesXiaohong Pan, Chunying Yang, John L Cleveland, et al.
Plos One|December 27, 2014
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolinMohammad Fallahi, Antonio L Amelio, John L Cleveland, et al.
Biologics : Targets & Therapy|August 27, 2009
Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistanceJennifer S Carew, Steffan T Nawrocki, Francis J Giles, et al.
Cancer Research|April 4, 2002
Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient miceChristine M Eischen, Jerold E Rehg, Stanley J Korsmeyer, et al.
Annals of Translational Medicine|January 17, 2017
CK1δ: an exploitable vulnerability in breast cancerLaura H Rosenberg, John L Cleveland, William R Roush, et al.
The EMBO Journal|March 12, 2003
Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesisJodi R Alt, Timothy C Greiner, John L Cleveland, et al.
The Journal of Clinical Investigation|December 22, 2007
Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesisKirsteen H Maclean, Frank C Dorsey, John L Cleveland, et al.
Pageof 16